InceptionR’s Voyager Therapeutics VYGR Stock Holding History

InceptionR’s Portfolio VYGR Stock Details VYGR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-10,053	Closed	-$79.5K	–	890
2024 Q2	$79.5K	Buy	+10,053	New	+$84.3K	0.02%	550

Other funds holding VYGR

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

EAM

Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

InceptionR's VYGR Position: Q3 2024 in Review

InceptionR sold out of Voyager Therapeutics (VYGR) in Q3 2024, closing a stake of 10,053 shares — an estimated $79.5K sold.

InceptionR first reported a position in VYGR in Q2 2024 and held it in 1 quarter. The position peaked at $79.5K in Q2 2024. 128 funds tracked by Wall St. Rank hold VYGR as of Q3 2024.

InceptionR reported no remaining Voyager Therapeutics position as of Q3 2024 after selling out during the quarter.
InceptionR sold 10,053 Voyager Therapeutics shares in Q3 2024, an estimated $79.5K.
InceptionR first reported a position in Voyager Therapeutics in Q2 2024 and held it in 1 quarter.
InceptionR's Voyager Therapeutics position peaked at $79.5K in Q2 2024.
128 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q3 2024.

Based on InceptionR's 13F filing for Q3 2024, filed 8 Nov 2024.